Literature DB >> 9124973

Circulatory resuscitation with left ventricular assist device support reduces interleukins 6 and 8 levels.

D J Goldstein1, N Moazami, J A Seldomridge, H Laio, R C Ashton, Y Naka, D J Pinsky, M C Oz.   

Abstract

BACKGROUND: Elevated tumor necrosis factor serum levels have been reported in patients with severe congestive heart failure. This study was designed to characterize the cytokine profile in patients with acute circulatory collapse.
METHODS: Blood drawn from 14 consecutive patients within 24 hours before undergoing left ventricular assist device placement and after at least 30 days of mechanical assistance or before transplantation was assayed for levels of interleukin 6, interleukin 8, and tumor necrosis factor-alpha.
RESULTS: Interleukin 6 level was elevated in 11 (79%), interleukin 8 in 10 (71%), and tumor necrosis factor in 2 (14%) of the 14 patients. After hemodynamic recovery, interleukin 6 levels decreased from 33.6 +/- 9 pg/mL to 11.3 +/- 4 pg/mL (p = 0.05) and interleukin 8 levels decreased from 122 +/- 34 pg/mL to 19.7 +/- 8 pg/mL (p = 0.005). Tumor necrosis factor-alpha levels did not vary significantly; they were associated with infection in 2 left ventricular assist device recipients and normalized after left ventricular assist device support. All patients had resolution of circulatory shock after mechanical support and had improvement in parameters of end-organ function.
CONCLUSIONS: Circulatory shock treated with left ventricular assist device placement is associated with a proinflammatory response similar to that seen in septic shock. The decrease in cytokine serum levels that follows hemodynamic recovery suggests that these cytokines may be markers of tissue damage and may modulate cardiac dysfunction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9124973     DOI: 10.1016/s0003-4975(96)01117-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

Review 1.  Reverse cardiac remodeling enabled by mechanical unloading of the left ventricle.

Authors:  Konstantinos G Malliaras; John V Terrovitis; Stavros G Drakos; John N Nanas
Journal:  J Cardiovasc Transl Res       Date:  2008-09-30       Impact factor: 4.132

2.  Left ventricular remodeling and myocardial recovery on mechanical circulatory support.

Authors:  Marc A Simon; Brian A Primack; Jeffrey Teuteberg; Robert L Kormos; Christian Bermudez; Yoshiya Toyoda; Hemal Shah; John Gorcsan; Dennis M McNamara
Journal:  J Card Fail       Date:  2009-11-14       Impact factor: 5.712

Review 3.  Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications.

Authors:  A P Bolger; S D Anker
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 4.  Current experience with left ventricular assist devices in patients with congestive heart failure.

Authors:  D Mancini; M Oz; A Beniaminovitz
Journal:  Curr Cardiol Rep       Date:  1999-05       Impact factor: 2.931

5.  Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.

Authors:  Turhan Kurum; Ersan Tatli; Mahmut Yuksel
Journal:  Tex Heart Inst J       Date:  2007

Review 6.  The Inflammatory Response to Ventricular Assist Devices.

Authors:  Gemma Radley; Ina Laura Pieper; Sabrina Ali; Farah Bhatti; Catherine A Thornton
Journal:  Front Immunol       Date:  2018-11-15       Impact factor: 7.561

7.  Left ventricular assist device implantation improves glycaemic control: a systematic review and meta-analysis.

Authors:  Nirav Patel; Jason A Gluck; Joseph Radojevic; Craig I Coleman; William L Baker
Journal:  ESC Heart Fail       Date:  2018-07-27

8.  Kidney Transplants From Donors on Extracorporeal Membrane Oxygenation Prior to Death Are Associated With Better Long-Term Renal Function Compared to Donors After Circulatory Death.

Authors:  Marilena Gregorini; Elena Ticozzelli; Massimo Abelli; Maria A Grignano; Eleonora F Pattonieri; Alessandro Giacomoni; Luciano De Carlis; Antonio Dell'Acqua; Rossana Caldara; Carlo Socci; Andrea Bottazzi; Carmelo Libetta; Vincenzo Sepe; Stefano Malabarba; Federica Manzoni; Catherine Klersy; Giuseppe Piccolo; Teresa Rampino
Journal:  Transpl Int       Date:  2022-02-08       Impact factor: 3.782

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.